Dimethyl sulfoxide toxicity kinetics in intact articular cartilage

被引：64

作者：

Elmoazzen H.Y. ^{[3
]}

Poovadan A. ^{[2
]}

Law G.K. ^{[2
]}

Elliott J.A.W. ^{[1
]}

McGann L.E. ^{[3
]}

Jomha N.M. ^{[2
]}

机构：

[1] Department of Chemical and Materials Engineering, University of Alberta, Edmonton

[2] Department of Surgery, University of Alberta Hospital, Edmonton, AB T6G 2B7

[3] Department of Lab Medicine and Pathology, University of Alberta, Edmonton

来源：

Cell and Tissue Banking | / 8卷 / 2期

基金：

加拿大健康研究院;

关键词：

Articular cartilage; DMSO; Toxicity; Transplantation; Vitrification;

D O I：

10.1007/s10561-006-9023-y

中图分类号：

学科分类号：

摘要：

Osteochondral defects can degenerate into osteoarthritis and currently there are no good treatment alternatives available to most Orthopaedic surgeons. Osteochondral allografting can restore damaged joint surfaces but its clinical use is limited by poor access to high quality tissue. Vitrification of osteochondral tissue would allow the banking of this tissue but requires high concentrations of cryoprotective agents. This study was designed to ascertain dimethyl sulfoxide (DMSO) toxicity kinetics to chondrocytes in situ after exposure to DMSO at different temperatures recorded as a function of time. Porcine osteochondral dowels were exposed to 1, 3, 5, and 6M DMSO at 4, 22, and 37°C for 0.5 min to 120 min. Chondrocyte recovery was determined by membrane integrity (Syto 13 and ethidium bromide) and mitochondrial (WST-1) assays. Results demonstrated that cell recovery was concentration, temperature and time dependent. At higher concentrations and temperatures, significant cell loss occurred within minutes. A rate constant calculated for chondrocyte death was dependent on temperature. 1 M DMSO appeared relatively non-toxic. This experiment established a method to examine systematically toxicity parameters for chondrocytes in situ and this data can be used to tailor vitrification protocols by limiting exposure temperature and time or lowering DMSO concentrations below toxic levels recorded. © Springer Science+Business Media B.V. 2006.

引用

页码：125 / 133

页数：8

共 58 条

[1]

Anderson A.F., Pagnani M.J., Osteochondritis dissecans of the femoral condyles. Long-term results of excision of the fragment, Am J Sports Med, 25, 6, pp. 830-834, (1997)

[2]

Aubin P.P., Cheah H.K., Davis A.M., Gross A.E., Long-term followup of fresh femoral osteochondral allografts for posttraumatic knee defects, Clin Orthop, 391, SUPPL., (2001)

[3]

Badley E.M., The impact of disabling arthritis, Arthritis Care Res, 8, 4, pp. 221-228, (1995)

[4]

Badley E.M., Wang P.P., The contribution of arthritis and arthritis disability to nonparticipation in the labor force: A Canadian example, J Rheumatol, 28, 5, pp. 1077-1082, (2001)

[5]

Ball S.T., Amiel D., Williams S.K., Tontz W., Chen A.C., Sah R.L., Bugbee W.D., The effects of storage on fresh human osteochondral allografts, Clin Orthop Relat Res, 418, pp. 246-252, (2004)

[6]

Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L., Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation, N Engl J Med, 331, 14, pp. 889-895, (1994)

[7]

Brittberg M., Tallheden T., Sjogren-Jansson B., Lindahl A., Peterson L., Autologous chondrocytes used for articular cartilage repair: An update, Clin Orthop, 391, SUPPL., (2001)

[8]

Brockbank K.G., Effects of cryopreservation upon vein function in vivo, Cryobiology, 31, 1, pp. 71-81, (1994)

[9]

Bugbee W.D., Convery F.R., Osteochondral allograft transplantation, Clin Sports Med, 18, 1, pp. 67-75, (1999)

[10]

Bujia J., Kremer D., Sudhoff H., Viviente E., Sprekelsen C., Wilmes E., Determination of viability of cryopreserved cartilage grafts, Eur Arch Otorhinolaryngol, 252, 1, pp. 30-34, (1995)

← 1 2 3 4 5 6 →